ZNF564
Basic information
Region (hg38): 19:12525373-12551542
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- Deficiency of alpha-mannosidase (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ZNF564 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 31 | 32 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 1 | 0 | 31 | 1 | 0 |
Variants in ZNF564
This is a list of pathogenic ClinVar variants found in the ZNF564 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-12526468-G-A | not specified | Uncertain significance (Jan 17, 2024) | ||
19-12526496-C-G | not specified | Uncertain significance (Oct 05, 2023) | ||
19-12526519-T-C | not specified | Uncertain significance (Nov 21, 2022) | ||
19-12526525-T-C | not specified | Uncertain significance (Aug 21, 2023) | ||
19-12526552-G-C | not specified | Uncertain significance (Dec 06, 2022) | ||
19-12526568-A-T | not specified | Uncertain significance (Sep 16, 2021) | ||
19-12526597-G-A | not specified | Uncertain significance (Jan 10, 2023) | ||
19-12526607-C-T | not specified | Uncertain significance (Sep 12, 2023) | ||
19-12526630-C-G | not specified | Uncertain significance (Feb 11, 2022) | ||
19-12526681-G-A | not specified | Uncertain significance (Jan 26, 2022) | ||
19-12526874-C-T | not specified | Uncertain significance (Nov 22, 2021) | ||
19-12526928-T-C | not specified | Uncertain significance (Dec 14, 2023) | ||
19-12526966-C-T | not specified | Uncertain significance (Oct 02, 2023) | ||
19-12526991-C-T | not specified | Uncertain significance (Oct 05, 2021) | ||
19-12526997-C-T | not specified | Uncertain significance (Jan 24, 2024) | ||
19-12527010-T-A | not specified | Uncertain significance (Jan 03, 2024) | ||
19-12527122-C-A | not specified | Uncertain significance (Jun 22, 2021) | ||
19-12527233-G-C | not specified | Uncertain significance (Feb 17, 2024) | ||
19-12527404-A-C | not specified | Uncertain significance (Oct 26, 2022) | ||
19-12527463-A-C | not specified | Uncertain significance (Sep 01, 2021) | ||
19-12527503-C-T | not specified | Uncertain significance (Dec 28, 2022) | ||
19-12527522-G-A | not specified | Uncertain significance (Apr 01, 2024) | ||
19-12527524-C-G | not specified | Uncertain significance (Apr 25, 2022) | ||
19-12527567-G-A | not specified | Uncertain significance (Jul 06, 2021) | ||
19-12527603-A-T | not specified | Uncertain significance (Apr 22, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ZNF564 | protein_coding | protein_coding | ENST00000339282 | 4 | 26173 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.355 | 0.596 | 125570 | 0 | 5 | 125575 | 0.0000199 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.08 | 241 | 293 | 0.823 | 0.0000142 | 3693 |
Missense in Polyphen | 58 | 92.189 | 0.62914 | 1165 | ||
Synonymous | -0.596 | 106 | 98.5 | 1.08 | 0.00000486 | 970 |
Loss of Function | 1.55 | 1 | 4.57 | 0.219 | 1.93e-7 | 57 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000450 | 0.0000440 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May be involved in transcriptional regulation.;
- Pathway
- Gene expression (Transcription);Generic Transcription Pathway;RNA Polymerase II Transcription
(Consensus)
Intolerance Scores
- loftool
- 0.727
- rvis_EVS
- -0.47
- rvis_percentile_EVS
- 23.25
Haploinsufficiency Scores
- pHI
- 0.188
- hipred
- N
- hipred_score
- 0.197
- ghis
- 0.561
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.927
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;positive regulation of transcription by RNA polymerase II
- Cellular component
- nucleoplasm
- Molecular function
- DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription factor activity;protein binding;transcription regulatory region DNA binding;metal ion binding